Sigilon Therapeutics, Inc.
USD22.47
-0.59 (-2.56%)
CEO
Rogerio Vivaldi Coelho MBA
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.90
Prev. Close
$23.06
Day Low
$22.09
Day High
$23.08
52W Low
$3.77
52W High
$28.00
Market Cap
$0.06B
Volume
0.08M
| -1.1 |
| 31 Dec 2020 | FY | 100.0% | -410.3% | -37.5% | -24.4% | 0.25 | 4.34 | -27.5 |
| 31 Dec 2019 | FY | 100.0% | -314.9% | 57.3% | -49.3% | -0.32 | 1.91 | -16.4 |
| 31 Dec 2018 | FY | 100.0% | -490.9% | 63.1% | -33.6% | -0.14 | 2.21 | -24.0 |
| -13.1 |
| 31 Dec 2022 | Q4 | 100.0% | -213.3% | -14.4% | -6.5% | 0.72 | 2.40 | -6.5 |
| 30 Sept 2022 | Q3 | 100.0% | -209.8% | -20.1% | -9.4% | 0.69 | 2.64 | -6.0 |
| 30 Jun 2022 | Q2 | 100.0% | -508.4% | -28.3% | -13.6% | 0.61 | 2.77 | -6.0 |
| 31 Mar 2022 | Q1 | 100.0% | -437.9% | -21.5% | -11.0% | 0.50 | 2.96 | -0.9 |
| 31 Dec 2021 | Q4 | 100.0% | -891.8% | -23.0% | -12.3% | 0.43 | 3.62 | -1.2 |
| 30 Sept 2021 | Q3 | 100.0% | -1035.2% | -21.6% | -12.3% | 0.38 | 3.52 | -2.2 |
| 30 Jun 2021 | Q2 | 100.0% | -755.8% | -18.4% | -11.0% | 0.32 | 3.75 | -4.1 |
| 31 Mar 2021 | Q1 | 100.0% | -641.4% | -14.7% | -9.3% | 0.28 | 5.31 | -9.3 |